Paper12378627
Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.
Chen XX and 3 others. World J Gastroenterol, 2002. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines. Papers, record 12378627. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12378627
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Colonic Neoplasms | Major topic |
| Antimetabolites, Antineoplastic | |
| Antineoplastic Agents | |
| Cisplatin | |
| Drug Resistance, Neoplasm | |
| Flow Cytometry | |
| Fluorouracil | |
| G1 Phase | |
| Humans | |
| Immunohistochemistry | |
| S Phase | |
| Tumor Cells, Cultured | |
| Tumor Suppressor Protein p53 |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11231942 | Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis. | Gastroenterology | 2001 | https://conductscience.org/library/papers/11231942 | PubMed |
| 2 | 9083327 | Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9083327 | PubMed |
| 3 | 11405176 | Mitomycin C and cisplatin enhanced the antitumor activity of p53-expressing adenovirus in cervical cancer cells. | Cancer Invest | 2001 | https://conductscience.org/library/papers/11405176 | PubMed |
| 4 | 10344753 | Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. | Cancer Res | 1999 | https://conductscience.org/library/papers/10344753 | PubMed |
| 5 | 11406570 | c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. | Cancer Res | 2001 | https://conductscience.org/library/papers/11406570 | PubMed |
| 6 | 10993958 | Survival of colorectal cancer cell lines treated with paclitaxel, radiation, and 5-FU: effect of TP53 or hMLH1 deficiency. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10993958 | PubMed |
| 7 | 11459832 | Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. | Genes Dev | 2001 | https://conductscience.org/library/papers/11459832 | PubMed |
| 8 | 10762058 | Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer. | Exp Mol Med | 2000 | https://conductscience.org/library/papers/10762058 | PubMed |
| 9 | 11307149 | Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival. | Int J Cancer | 2001 | https://conductscience.org/library/papers/11307149 | PubMed |
| 10 | 10442360 | UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer. | Oncology (Williston Park) | 1999 | https://conductscience.org/library/papers/10442360 | PubMed |
| 11 | 10967750 | Molecular biology of esophageal cancer. | Chest Surg Clin N Am | 2000 | https://conductscience.org/library/papers/10967750 | PubMed |
| 12 | 9233776 | hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. | Oncogene | 1997 | https://conductscience.org/library/papers/9233776 | PubMed |
| 13 | 11481424 | DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11481424 | PubMed |
| 14 | 8958035 | Colorectal cancer: the challenge. | Eur J Cancer | 1996 | https://conductscience.org/library/papers/8958035 | PubMed |
| 15 | 10928287 | Apoptosis and cancer chemotherapy. | Cell Tissue Res | 2000 | https://conductscience.org/library/papers/10928287 | PubMed |
| 16 | 11028915 | Molecular mechanisms involved in cisplatin cytotoxicity. | Cell Mol Life Sci | 2000 | https://conductscience.org/library/papers/11028915 | PubMed |
| 17 | 10080673 | Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy. | Tumori | 1998 | https://conductscience.org/library/papers/10080673 | PubMed |
| 18 | 9822382 | Requirement for p53 and p21 to sustain G2 arrest after DNA damage. | Science | 1998 | https://conductscience.org/library/papers/9822382 | PubMed |
| 19 | 10644941 | p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma. | Oncology | 2000 | https://conductscience.org/library/papers/10644941 | PubMed |
| 20 | 9485005 | Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability. | Cancer Res | 1998 | https://conductscience.org/library/papers/9485005 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42074036 | PRDM Proteins Orchestrate Colorectal Cancer Tumorigenesis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074036 | PubMed |
| 37064165 | Construction of multiple concentration gradients for single-cell level drug screening. | Microsyst Nanoeng | 2023 | https://conductscience.org/library/papers/37064165 | PubMed |
| 30186375 | Combined antitumor effects of P-5m octapeptide and 5-fluorouracil on a murine model of H22 hepatoma ascites. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/30186375 | PubMed |
| 29115590 | Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes. | Int J Oncol | 2018 | https://conductscience.org/library/papers/29115590 | PubMed |
| 28053903 | The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines. | J Korean Assoc Oral Maxillofac Surg | 2016 | https://conductscience.org/library/papers/28053903 | PubMed |
| 27618077 | Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer. | Int J Environ Res Public Health | 2016 | https://conductscience.org/library/papers/27618077 | PubMed |
| 26491668 | Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell Growth via Inhibition of the ERK-Dependent EGF Receptor Signaling Pathway. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26491668 | PubMed |
| 25736303 | Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis. | Exp Biol Med (Maywood) | 2015 | https://conductscience.org/library/papers/25736303 | PubMed |
| 23521834 | Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines. | BMC Pharmacol Toxicol | 2013 | https://conductscience.org/library/papers/23521834 | PubMed |
| 21975339 | Molecular changes consistent with increased proliferation and invasion are common in rectal cancer. | Clin Transl Oncol | 2011 | https://conductscience.org/library/papers/21975339 | PubMed |
| 21786442 | The bacterial protein azurin enhances sensitivity of oral squamous carcinoma cells to anticancer drugs. | Yonsei Med J | 2011 | https://conductscience.org/library/papers/21786442 | PubMed |
| 17461495 | Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17461495 | PubMed |
| 17109103 | The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. | Int J Colorectal Dis | 2007 | https://conductscience.org/library/papers/17109103 | PubMed |
| 15154969 | A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine. | BMC Cancer | 2004 | https://conductscience.org/library/papers/15154969 | PubMed |
| 14716826 | Ethylene diamine tetraacetic acid-induced colonic crypt cell proliferation in rats. | World J Gastroenterol | 2004 | https://conductscience.org/library/papers/14716826 | PubMed |
| 14669314 | Comparative evaluation of immune response after laparoscopical and open total mesorectal excisions with anal sphincter preservation in patients with rectal cancer. | World J Gastroenterol | 2003 | https://conductscience.org/library/papers/14669314 | PubMed |
| 12918123 | Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats. | World J Gastroenterol | 2003 | https://conductscience.org/library/papers/12918123 | PubMed |
| 12800232 | Synergistic antitumor effect of TRAIL and doxorubicin on colon cancer cell line SW480. | World J Gastroenterol | 2003 | https://conductscience.org/library/papers/12800232 | PubMed |
| 12532439 | The study of chemiluminescence in gastric and colonic carcinoma cell lines treated by anti-tumor drugs. | World J Gastroenterol | 2003 | https://conductscience.org/library/papers/12532439 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PRDM2 | 7799 | PubTator's text mining | https://conductscience.org/library/genes/7799 | NCBI Gene |
| TGFBR2 | 7048 | PubTator's text mining | https://conductscience.org/library/genes/7048 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12378627
GET https://conductscience.org/api/papers/v1/12378627/references?page=2